Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition

Abstract Background Pulmonary fibrosis is a late manifestation of acute respiratory distress syndrome (ARDS). Sepsis is a major cause of ARDS, and its pathogenesis includes endotoxin-induced vascular injury. Recently, endothelial-to-mesenchymal transition (EndMT) was shown to play an important role...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Toshio Suzuki, Yuji Tada, Santhi Gladson, Rintaro Nishimura, Iwao Shimomura, Satoshi Karasawa, Koichiro Tatsumi, James West
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2017-10-01
סדרה:	Respiratory Research
נושאים:	Endothelial-to-mesenchymal transition Pulmonary fibrosis Dipeptidyl peptidase 4 Post ARDS pulmonary fibrosis
גישה מקוונת:	http://link.springer.com/article/10.1186/s12931-017-0660-4
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!